Lenvatinib (L) Versus Sorafenib (S) Second-Line Therapy in Hepatocellular Carcinoma (Hcc) Patients (P) Progressed to Atezolizumab plus Bevacizumab (Ab)

AuthID
 P-017-5PF
20
Author(s)
Rimini, M
·
Foti, S
·
Camera, S
·
Rossari, F
·
Amadeo, E
·
Vitiello, F
·
Tada, T
·
Suda, G
·
Shimose, S
·
Kudo, M
·
Yoo, C
·
Cheon, J
·
Finkelmeier, F
·
Lim, HY
·
Presa, J
·
Mascia, L
·
Cascinu, S
·
Scartozzi, M
·
Gardini, AC
Document Type
Abstract
Year published
2024
Published
in ANNALS OF ONCOLOGY, ISSN: 0923-7534
Volume: 35, Pages: S83-S83 (1)
Conference
Gastrointestinal Cancers Congress of the European-Society-For-Medical-Oncology (Esmo), Date: JUN 26-29, 2024, Location: Munich, GERMANY
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:001299993900183
Source Identifiers
ISSN: 0923-7534
Export Publication Metadata
Marked List
 Add to Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2026 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service